Evidence map›Paper›PMID 40281751›Full record

ArticleBioengineering (Basel, Switzerland)2025

Ultrasound-Based Deep Learning Radiomics Models for Predicting Primary and Secondary Salivary Gland Malignancies: A Multicenter Retrospective Study.

Zhen Xia, Xiao-Chen Huang, Xin-Yu Xu, Qing Miao, Ming Wang, Meng-Jie Wu, Hao Zhang, Qi Jiang, Jing Zhuang, Qiang Wei and 1 more

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zhen XiaDepartment of Ultrasound, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
Xiao-Chen HuangDepartment of Pathology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
Xin-Yu XuDepartment of Pathology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
Qing MiaoDepartment of Ultrasound, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
Ming WangDepartment of Ultrasound, The 902nd Hospital of the Joint Logistics Support Force, Bengbu 233000, China.
Meng-Jie WuDepartment of Ultrasound, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
Hao ZhangDepartment of Ultrasound, Affiliated Hospital of Nantong University, Nantong 226006, China.
Qi JiangDepartment of Ultrasound, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing 211100, China.
Jing ZhuangDepartment of Ultrasound, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
Qiang WeiDepartment of Ultrasound, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
Wei ZhangDepartment of Ultrasound, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.ORCID 0009-0004-7855-7949

Funding

Jiangsu Cancer Hospital ZL202217, ZJ202208 and QZLC202418
6 · The paper itself

Abstract

backgroundPrimary and secondary salivary gland malignancies differ significantly in treatment and prognosis. However, conventional ultrasonography often struggles to differentiate between these malignancies due to overlapping imaging features. We aimed to develop and evaluate noninvasive diagnostic models based on traditional ultrasound features, radiomics, and deep learning-independently or in combination-for distinguishing between primary and secondary salivary gland malignancies.

methodsThis retrospective study included a total of 140 patients, comprising 68 with primary and 72 with secondary salivary gland malignancies, all pathologically confirmed, from four medical centers. Ultrasound features of salivary gland tumors were analyzed, and a radiomics model was established. Transfer learning with multiple pre-trained models was used to create deep learning (DL) models from which features were extracted and combined with radiomics features to construct a radiomics-deep learning (RadiomicsDL) model. A combined model was further developed by integrating ultrasound features. Least absolute shrinkage and selection operator (LASSO) regression and various machine learning algorithms were employed for feature selection and modeling. The optimal model was determined based on the area under the receiver operating characteristic curve (AUC), and interpretability was assessed using SHapley Additive exPlanations (SHAP).

resultsThe RadiomicsDL model, which combines radiomics and deep learning features using the Multi-Layer Perceptron (MLP), demonstrated the best performance on the test set with an AUC of 0.807. This surpassed the performances of the ultrasound (US), radiomics, DL, and combined models, which achieved AUCs of 0.421, 0.636, 0.763, and 0.711, respectively. SHAP analysis revealed that the radiomic feature Wavelet_LHH_glcm_SumEntropy contributed most significantly to the mode.

conclusionsThe RadiomicsDL model based on ultrasound images provides an efficient and non-invasive method to differentiate between primary and secondary salivary gland malignancies.

Indexed as

deep learninginterpretabilityradiomicssalivary gland malignanciesultrasound

Identifiers

PMID40281751
PMCPMC12024528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.